Greater Cannabis Company (GCAN) Short term Debt (2016 - 2022)

Greater Cannabis Company's (GCAN) quarterly Short term Debt came in at $260000.0 in Q4 2022, little changed year-on-year from $260000.0 in Q4 2021, and little changed quarter-over-quarter from $260000.0 in Q3 2022.

Greater Cannabis Company (GCAN) Short term Debt (2016 - 2022) Analysis & Trends

Greater Cannabis Company's Short term Debt history runs 7 years deep, the most recent figure standing at $260000.0 for Q4 2022.

  • On a quarterly basis, Short term Debt changed 0.0% year-over-year to $260000.0 in Q4 2022; TTM through Dec 2022 was $260000.0, a 0.0% change from a year earlier, with the FY2022 full-year figure at $260000.0, changed 0.0% from the prior year.
  • Short term Debt held at $260000.0 in Q4 2022 per GCAN's latest filing, from $260000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $260000.0 in Q3 2018 and bottomed at $12245.0 in Q1 2018.
  • The 5-year median for Short term Debt is $260000.0 (2018), against an average of $235577.2.
  • Across the five-year window, Short term Debt surged 5870.15% in 2018 and changed 0.0% in 2019, its largest moves.
  • Year by year, Short term Debt stood at $260000.0 in 2018, then changed by 0.0% to $260000.0 in 2019, then changed by 0.0% to $260000.0 in 2020, then changed by 0.0% to $260000.0 in 2021, then changed by 0.0% to $260000.0 in 2022.
  • Per Business Quant, the three latest GCAN Short term Debt figures stand at $260000.0 (Q4 2022), $260000.0 (Q3 2022), and $260000.0 (Q2 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Greater Cannabis Company 292,929.85 292,929.85 -

Historic Data

Download Data
DateValue
Dec 31, 2022 260,000.00
Sep 30, 2022 260,000.00
Jun 30, 2022 260,000.00
Mar 31, 2022 260,000.00
Dec 31, 2021 260,000.00
Sep 30, 2021 260,000.00
Jun 30, 2021 260,000.00
Mar 31, 2021 260,000.00
Dec 31, 2020 260,000.00
Sep 30, 2020 260,000.00
Jun 30, 2020 260,000.00
Mar 31, 2020 260,000.00
Dec 31, 2019 260,000.00
Sep 30, 2019 260,000.00
Jun 30, 2019 260,000.00
Mar 31, 2019 260,000.00
Dec 31, 2018 260,000.00
Sep 30, 2018 260,000.00
Jun 30, 2018 19,299.00
Mar 31, 2018 12,245.00